Cell Rep 16 , 23592372, doi:10.1016/j.celrep.2016.07.063 (2016)
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide primarily targets GLP-1 pathways
HOW IT WORKS BOOK NOW Melanotan 2 works by activating melanocortin receptors, particularly MC1R, which stimulates melanin production in skin cells called melanocytes
GHK-Cu and the nervous system The peptide exhibits neuroprotective properties, supporting neuronal regeneration and reducing oxidative stress in nerve cells
NEW data has shed light on the potential benefits of semaglutide, a medication primarily used to treat type 2 diabetes mellitus (T2DM) and obesity, in addressing tobacco use disorders (TUDs)
A therapeutic alternative for hemodialysis patients